Breaking News on Food & Beverage Development - EuropeUS edition | Asian edition
Supplier info centre > Related news headlines
All news headlines forMerck KGaASee also : Supplier info centre | All products for Merck KGaA |
 |
Pharmaceutical manufacturing: people on the move
17-Apr-2008 - Dr Hans Groeger has been appointed to the role of site manager at Roche Carolina's Florence facility.
Merck KGaA still has an eye to buy in pharma
12-Mar-2008 - Germany's Merck KGaA is still on the lookout for acquisitions or in-licensing deals to fill out its pharmaceutical business following the purchase and integration of Swiss biotech Serono.
Merck, Vertex halt aurora kinase cancer trial
22-Nov-2007 - Merck & Co. and its partner Vertex Pharmaceuticals have stopped enrolling cancer patients to the clinical trial of its aurora kinase trial after one patient suffered heart problems.
Merck KGaA pulls out of diabetes research
24-Oct-2007 - In a shock announcement at its third quarter financial results, Merck KGaA has said it will stop its diabetes research and partner out any current programmes.
Pharmaceutical manufacturing: people on the move
12-Sep-2007 - Crucell, Endo Pharmaceuticals, Wyeth Pharmaceuticals and SupplyScape have all had people on the move in the world of pharmaceutical manufacturing.
BioVascular, Revitus join forces to target vascular disease
11-Sep-2007 - Two privately held biotech companies developing compounds to prevent blood clots have merged as their second drug candidate enters clinical trials.
Biomira, Antisoma in lung cancer drug race
06-Sep-2007 - Biomira and Antisoma have both released clinical data showing their respective drugs, a vaccine vs. a standard molecule, improve anticancer responses and survival for patients with non-small cell lung cancer (NSCLC).
Micromet sticks to tough cancer target
30-Aug-2007 - Micromet is sticking to its research into cell adhesion antibodies to treat breast cancer and other tumours, hoping it will have more luck than GlaxoSmithKline and Centocor's failed attempt.
Merck KGaA disappointed by Parkinson's drug results
23-Aug-2007 - Newron Pharmaceuticals and its partner Merck KGaA suffered a disappointment yesterday, when their investigational Parkinson's disease drug failed a pivotal clinical trial.
Pharmaceutical outsourcing: people on the move
24-Jul-2007 - Althea Technologies, Hyaluron, WuXi PharmaTech, Draxis Health, Hill Top Research, Premier Research and Holmes Biopharma have all had people on the move in the world of pharmaceutical outsourcing.
Pfizer tops list of most sought-after firms
10-Jul-2007 - Pfizer, Novartis and Sanofi-Aventis were the companies who attracted the most interest from pharmaceutical business researchers in the first half of the year, according to a UK pharma market research firm.
SkyePharma's controlled release doze gets the nod from Somnus
27-Jun-2007 - SkyePharma's novel controlled-release sleep therapeutic has been licensed by Somnus Therapeutics in an exclusive worldwide development and commercialisation deal.